Clinical Trial Update: Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing abatacept versus tocilizumab for rheumatoid arthritis in patients who inadequate respond to TNF inhibitors is ongoing with unknown sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Abatacept (abatacept)
• Tocilizumab (tocilizumab)

Snippet

Sponsor: Lille Catholic University | Conditions: Arthritis, Rheumatoid | Phase 4 | Status: UNKNOWN